β-cryptoxanthin and fatty liver disease: new insights.

Hepatobiliary Surg Nutr · 2023 · PMC10282678 · PMID 37351127

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While there was evidence of decreased hepatic inflammation in mice receiving the β-cryptoxanthin supplement, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.